Understanding Medicare Part B Payer Strategies
Medicare Advantage payers juggle a broad set of legislative and regulatory policy changes, several of which, including high-impact IRA components, are compounded by the uncertainty of their eventual implementation. Payers expect these policies to result in changes to an array of market impacts, including new pressures to biopharma contracts and even stricter utilization management.
Through this new report from NAVLIN Insights, understand the benefit design trends in Medicare Part B and the anticipated effects of recent policy changes on key stakeholders and contracting dynamics with biopharma. Identify the risks and opportunities biopharma faces as dynamics change and the impact on the market and stakeholders in 2024 and beyond.
A full report with additional insights is available as part of the NAVLIN Insights subscription. Contact us at [email protected] for access and to learn more about NAVLIN by EVERSANA and our innovative market research solutions.